142 related articles for article (PubMed ID: 35813220)
1. Alpha Protein Kinase 2 Promotes Esophageal Cancer via Integrin Alpha 11.
Ainiwaer J; Zhang L; Niyazi M; Awut E; Zheng S; Sheyhidin I; Dai J
Biomed Res Int; 2022; 2022():7676582. PubMed ID: 35813220
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑200a promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through extensive target genes.
Yang B; Liu Y; Li L; Deng H; Xian L
Mol Med Rep; 2020 May; 21(5):2073-2084. PubMed ID: 32323771
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.
Du J
Anticancer Drugs; 2019 Jul; 30(6):596-603. PubMed ID: 30672777
[TBL] [Abstract][Full Text] [Related]
5. ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A.
Wang Y; Wu J; Luo W; Zhang H; Shi G; Shen Y; Zhu Y; Ma C; Dai B; Ye D; Zhu Y
Cell Death Dis; 2021 Jul; 12(7):661. PubMed ID: 34210956
[TBL] [Abstract][Full Text] [Related]
6. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
[No Abstract] [Full Text] [Related]
7. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin E inhibits esophageal carcinoma cell proliferation, migration, and invasion by suppressing Rac1 expression through PI3K/AKT/mTOR pathway.
Zhang L; Liang H; Xin Y
Anticancer Drugs; 2020 Sep; 31(8):847-855. PubMed ID: 32568828
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic microRNA-301b regulates tumor repressor dystrobrevin alpha to facilitate cell growth, invasion and migration in esophageal cancer.
Fu G; Pei Z; Song N
Esophagus; 2021 Apr; 18(2):315-325. PubMed ID: 32737801
[TBL] [Abstract][Full Text] [Related]
10. Poly(A)-specific ribonuclease protein promotes the proliferation, invasion and migration of esophageal cancer cells.
Zhang FW; Xie XW; Chen MH; Tong J; Chen QQ; Feng J; Chen FT; Liu WQ
World J Gastroenterol; 2023 Aug; 29(31):4783-4796. PubMed ID: 37664151
[TBL] [Abstract][Full Text] [Related]
11. Hsa_circ_0065217 promotes growth and metastasis of renal cancer through regulating the miR-214-3p-ALPK2 axis.
Yan JS; Chen Q; Li YL; Gao YQ
Cell Cycle; 2021 Dec; 20(23):2519-2530. PubMed ID: 34705617
[TBL] [Abstract][Full Text] [Related]
12. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
[TBL] [Abstract][Full Text] [Related]
13. Circ_0006948 Contributes to Cell Growth, Migration, Invasion and Epithelial-Mesenchymal Transition in Esophageal Carcinoma.
Yue M; Liu Y; Zuo T; Jiang Y; Pan J; Zhang S; Shen X
Dig Dis Sci; 2022 Feb; 67(2):492-503. PubMed ID: 33630215
[TBL] [Abstract][Full Text] [Related]
14. Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy.
Li ZY; Li HF; Zhang YY; Zhang XL; Wang B; Liu JT
World J Gastroenterol; 2020 Apr; 26(15):1775-1791. PubMed ID: 32351293
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of ALPK2 inhibits the development and progression of Ovarian Cancer.
Zhu X; Yan S; Xiao S; Xue M
Cancer Cell Int; 2020; 20():267. PubMed ID: 32595416
[TBL] [Abstract][Full Text] [Related]
16. [MIR503HG promotes esophageal squamous cell carcinoma cell proliferation, invasion and migration via hsa-miR-503 pathway].
Gong TY; Chen HY; Liu ZH
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1160-1167. PubMed ID: 36380664
[No Abstract] [Full Text] [Related]
17. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
Yin Y; Du L; Li X; Zhang X; Gao Y
J Cell Physiol; 2019 Aug; 234(8):12757-12770. PubMed ID: 30537034
[TBL] [Abstract][Full Text] [Related]
18. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Wang G; Sun J; Zhao H; Li H
Med Sci Monit; 2018 Oct; 24():7689-7696. PubMed ID: 30368517
[TBL] [Abstract][Full Text] [Related]
20. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
